Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PK Study of TV-46046 in Healthy Women
NCT04682353Phase 1Completed
- Sponsor
- Teva Pharmaceutical Industries Ltd.
- Start
- Dec 2020
- Primary completion
- Jul 2022
- Modality
- Small Molecules
- Countries
- 2
01
Overview
Phase 1, randomised, open-label trial of dmpa-sc in contraception (4 arms), sponsored by Teva Pharmaceutical Industries Ltd. Primary endpoints: Maximum Observed Serum Concentration, Time to Reach Cmax and 3 more. Started Dec 2020; status: completed.
02
Drugs
dmpa-sc
03
Conditions
contraception
Beyond the preview
Go deeper on NCT04682353.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04682353.